🇺🇸 Hydrocortisone Oral in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 2 reports (18.18%)
  2. Bone Marrow Toxicity — 1 report (9.09%)
  3. Bronchopulmonary Aspergillosis — 1 report (9.09%)
  4. Dizziness — 1 report (9.09%)
  5. Dysphagia — 1 report (9.09%)
  6. Dyspnoea — 1 report (9.09%)
  7. Haematocrit Decreased — 1 report (9.09%)
  8. Haemoglobin Decreased — 1 report (9.09%)
  9. Hypotension — 1 report (9.09%)
  10. Infusion Related Reaction — 1 report (9.09%)

Source database →

Hydrocortisone Oral in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Hydrocortisone Oral approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hydrocortisone Oral in United States?

University of Texas Southwestern Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.